Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Operating Margin
Middle East Pharmaceutical Industries Company SJSC
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
SA |
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
2.4B SAR |
20%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
779.4B USD |
38%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK |
48%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
236.5B CHF |
32%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177B GBP |
23%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.9B USD |
36%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.7B CHF |
32%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.8B USD |
25%
|
Middle East Pharmaceutical Industries Company SJSC
Glance View
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Middle East Pharmaceutical Industries Company SJSC's most recent financial statements, the company has Operating Margin of 20.5%.